CDNA - CareDx, Inc
NEXT EARNINGS:
Apr 30, 2026
EPS Est: $-0.03
|
Rev Est: $100.4M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$22.00
DETAILS
HIGH:
$26.00
LOW:
$18.00
MEDIAN:
$22.00
CONSENSUS:
$22.00
UPSIDE:
14.29%
Market Cap:
990.08M
Volume:
583,076
Avg Volume:
726,655
52 Week Range:
10.96-22.947
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Beta:
2.51
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
644
IPO Date:
2014-07-17
EPS (TTM):
1.00
P/E Ratio:
-47.01
Revenue (TTM):
333.79M
Total Assets:
491.05M
Total Debt:
28.37M
Cash & Equiv:
114.69M
Rev Growth (5Y):
21.3%
EPS Growth (5Y):
22.6%
FCF Growth (5Y):
N/A
ROCE:
-13.4%
Debt/Equity:
0.07
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-24 | $-0.08 | $0.24 | -133.5% | $108.4M | $102.7M | +5.5% |
| 2025-11-04 | $0.28 | $0.13 | +115.4% | $100.1M | $102.8M | -2.6% |
| 2025-08-06 | $0.10 | $0.12 | -16.7% | $86.7M | $95.3M | -9.0% |
| 2025-04-30 | $0.09 | $0.06 | +50.0% | $84.7M | $84.5M | +0.2% |
| 2025-02-26 | $0.18 | $0.05 | +260.0% | $86.6M | $84.6M | +2.4% |
| 2024-11-04 | $0.14 | $0.01 | +1300.0% | $82.9M | $82.2M | +0.9% |
| 2024-07-31 | $0.25 | $-0.13 | +292.3% | $92.3M | $79.5M | +16.0% |
| 2024-05-09 | $-0.03 | $-0.19 | +84.2% | $72.0M | $63.1M | +14.1% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 333.79M | 280.32M | 321.79M | 296.40M | 192.19M | 127.07M | 76.57M | 48.32M | 40.63M | 28.14M | 27.31M | 22.10M |
| Net Income | 52.55M | (190.28M) | (76.61M) | (30.66M) | (18.71M) | (21.97M) | (46.76M) | (55.47M) | (39.47M) | (13.71M) | 781,000 | (3.54M) |
| EPS | 1.00 | -3.54 | -1.44 | -0.59 | -0.40 | -0.52 | -1.31 | -2.38 | -2.39 | -1.16 | 0.13 | -0.48 |
| Total Assets | 491.05M | 466.83M | 542.99M | 566.62M | 368.51M | 151.74M | 130.70M | 83.56M | 76.73M | 55.64M | 61.14M | 9.87M |
| Total Debt | 28.37M | 34.22M | 39.00M | 21.35M | 18.10M | 5.39M | 172,000 | 34.06M | 23.94M | 15.75M | 11.41M | 15.42M |
| Cash & Equivalents | 114.69M | 82.20M | 89.92M | 348.49M | 134.67M | 38.22M | 64.62M | 16.89M | 17.26M | 29.89M | 36.43M | 5.13M |
| Operating Cash Flow | 38.05M | (18.39M) | (25.24M) | (19.29M) | 33.43M | (2.77M) | (4.01M) | (14.31M) | (16.52M) | (9.75M) | (3.35M) | (546,000) |
| Free Cash Flow | 31.56M | (27.63M) | (49.57M) | (39.55M) | 23.07M | (6.12M) | (11.24M) | (14.49M) | (17.07M) | (10.95M) | (4.08M) | (644,000) |
| FCF per Share | 0.60 | -0.51 | -0.93 | -0.76 | 0.50 | -0.15 | -0.32 | -0.62 | -1.03 | -0.93 | -0.70 | -0.09 |
| Book Value | 378.43M | 261.33M | 430.91M | 465.88M | 277.68M | 99.00M | 95.93M | (6.13M) | 19.48M | 29.49M | 41.30M | (150.67M) |
| Cash & ST Investments | 260.65M | 235.42M | 293.09M | 348.49M | 224.70M | 38.22M | 64.62M | 16.89M | 17.26M | 29.89M | 36.43M | 5.13M |
| ROC Equity | 0.14 | -0.73 | -0.18 | -0.07 | -0.07 | -0.22 | -0.49 | N/A | -2.03 | -0.46 | 0.02 | N/A |